rxstat › Shortages › Ixekizumab

Ixekizumab (Taltz) shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Ixekizumab has no current shortage reported in Canada. It has been in shortage before; the history is below.

A biologic injection used to treat plaque psoriasis and psoriatic arthritis.

Products affected

0 / 2

Reports on file

Shortage history

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Resolved

TALTZ

80MG · SOLUTION · ELI LILLY CANADA INC

DIN 02455102 · ended Feb 28, 2025 · Delay in shipping of the drug.

Resolved

TALTZ

80MG · SOLUTION · ELI LILLY CANADA INC

DIN 02455110 · ended Jun 27, 2022 · Delay in shipping of the drug.

What's happening

There are no active shortage reports for Ixekizumab. Health Canada has 2 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Ixekizumab is classified under “IMMUNOSUPPRESSANTS” (ATC L04AC).

Recent changes

No changes recorded yet.

Common questions

What is Ixekizumab used for?

A biologic injection used to treat plaque psoriasis and psoriatic arthritis.

When will Ixekizumab be back in stock in Canada?

Ixekizumab has no active shortage; supply is normal per Health Canada reports.

Why is Ixekizumab in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (immunosuppressants)

Apremilast Widespread shortage 2 of 3 reported products affected Adalimumab (Hulio) Partial shortage 1 of 7 reported products affected Apremilast Partial shortage 1 of 1 reported products affected · est. return Sep 25, 2026 Basiliximab (Simulect) Partial shortage 1 of 1 reported products affected Cyclosporine (Restasis Multidose) Partial shortage 1 of 9 reported products affected · est. return Jul 30, 2027 Fingolimod (Gilenya) Partial shortage 3 of 8 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.